Fri, March 16, 2018
Thu, March 15, 2018
Wed, March 14, 2018
Tue, March 13, 2018
Mon, March 12, 2018

David Lebowitz Maintained (SNDX) at Buy with Decreased Target to $24 on, Mar 14th, 2018

David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Decreased Target from $25 to $24 on, Mar 14th, 2018.

David has made no other calls on SNDX in the last 4 months.



There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Madhu Kumar of "B. Riley Securities" Initiated at Strong Buy and Held Target at $40 on, Friday, January 5th, 2018